Tax Planning
Maximizing Malaysia’s Budget 2026 Reliefs: What Expats & Returning Experts Should Leverage
Malaysia’s 2026 tax changes include expanded vaccine reliefs, enhanced deductions for medical care/parents, and special flat 15 % rates for returning experts – here’s how expatriates and professionals coming home can benefit.
By NomadicTax Research Team • 5-8 min read • August 14, 2026
## Key reliefs & incentives introduced in Budget 2026
- **Vaccination expense relief**: Previously limited to specific vaccines, now includes *all NPRA-registered vaccines* for self, spouse, children. ([hasil.gov.my](https://www.hasil.gov.my/media/arvlrzh5/spesifikasi-kaedah-pengiraan-berkomputer-pcb-2026.pdf?utm_source=openai))
- **Medical treatment, special needs & carer expenses for parents/grandparents**: Expanded scope including vaccinations under approved list; relief for full medical check-ups capped at RM1,000 continues. ([hasil.gov.my](https://www.hasil.gov.my/media/arvlrzh5/spesifikasi-kaedah-pengiraan-berkomputer-pcb-2026.pdf?utm_source=openai))
- **Tax Incentive for Returning Experts (REP)**: Foreign nationals returning to Malaysia may elect a **flat 15 % tax deduction rate** on employment income for 5 consecutive Years of Assessment. ([hasil.gov.my](https://www.hasil.gov.my/media/zejnpxwe/ku-no1-tahun-2026-tax-incentive-for-returning-expert-programme-versi-bi.pdf?utm_source=openai))
## Who can benefit most
- **Expats returning home** under REP: choose start year to align with full eligibility; plan income based on whether partial year or full year; use flat rate for employer’s MTD (Monthly Tax Deduction). Example: returning mid-2024 vs commencing work in early 2025. ([hasil.gov.my](https://www.hasil.gov.my/media/zejnpxwe/ku-no1-tahun-2026-tax-incentive-for-returning-expert-programme-versi-bi.pdf?utm_source=openai))
- **Individuals with family overseas**: Those supporting elderly parents or grandparents may get tax relief for medical, carer, and vaccination costs.
- **Regular taxpayers** who already claim reliefs: ensure vaccination receipts are from NPRA-registered vaccines to qualify.
## How to claim & enforce properly
- Check payroll software or employer practices: flat 15 % MTD needs submission of SATK (Letter of election) to employer. Keep copy in case of audit. ([hasil.gov.my](https://www.hasil.gov.my/media/zejnpxwe/ku-no1-tahun-2026-tax-incentive-for-returning-expert-programme-versi-bi.pdf?utm_source=openai))
- Keep proof of vaccine registration (NPRA list) and receipts. Be cautious of unapproved vaccines.
- For medical treatment or carer expenses, ensure expense is arms-length, invoice issued correctly, and support documentation available.
- Monitor updates to electronic invoicing (e-Invois): PKPS e-Invois program, under HASiL, gives businesses, especially SMEs, opportunity for voluntary compliance with fewer penalties. ([hasil.gov.my](https://www.hasil.gov.my/e-invois/komunikasi-dan-hebahan/kenyataan-media/?utm_source=openai))
## Example strategy
**Example**: Dr. Lee, who returned to Malaysia in mid-2025 under REP and making RM250,000/year:
- **Option A**: Start the 5-YA REP in YA 2025, though only part-income earned.
- **Option B**: Defer start to YA 2026 to have full 12 months income under flat 15 %. May produce lower overall tax burden.
- He also supports his grandmother medically: vaccination receipts and expenses tied to approved vaccines will get deductions. Use flat rate for MTD to reduce tax payable each month, keeping cash flow smoother.
## Actionable checklist
- [ ] Confirm NPRA registration for any vaccines before incurring cost.
- [ ] If returning under REP, notify employer with SATK and choose start YA carefully.
- [ ] Organize documentation for parents/grandparents’ medical expenses in advance.
- [ ] SMEs & businesses to leverage PKPS program for e-Invois to reduce compliance risk.
With these changes, the 2026 policy environment in Malaysia is offering multiple tools for expats, returning professionals, and taxpayers with family caregiving responsibilities to better manage tax cost and optimize cash flow.